0001493152-23-004168.txt : 20230209
0001493152-23-004168.hdr.sgml : 20230209
20230209201150
ACCESSION NUMBER: 0001493152-23-004168
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230209
FILED AS OF DATE: 20230209
DATE AS OF CHANGE: 20230209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DelAversano Robert J
CENTRAL INDEX KEY: 0001728262
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54318
FILM NUMBER: 23608085
MAIL ADDRESS:
STREET 1: 217 W. MAIN STREET
CITY: SOMERVILLE
STATE: NJ
ZIP: 08876
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ONCOSEC MEDICAL Inc
CENTRAL INDEX KEY: 0001444307
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980573252
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 820 BEAR TAVERN ROAD
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: (858) 210-7333
MAIL ADDRESS:
STREET 1: 820 BEAR TAVERN ROAD
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: NetVentory Solutions, Inc.
DATE OF NAME CHANGE: 20080902
4
1
ownership.xml
X0306
4
2023-02-09
0
0001444307
ONCOSEC MEDICAL Inc
ONCS
0001728262
DelAversano Robert J
C/O ONCOSEC MEDICAL INCORPORATED
24 NORTH MAIN STREET
PENNINGTON
NJ
08534
0
1
0
0
VP, Finance
Common Stock
2023-02-09
4
S
0
40
1.37
D
1008
D
In connection with the vesting of 49 RSUs on February 1, 2023, a total of 40 shares were sold in order to satisfy the reporting person's tax withholding obligations. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies.
Effective as of 12:01 a.m. Eastern Time on November 9, 2022, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-22.
/s/ Robert J. DelAversano
2023-02-09